Chemotherapy for urothelial tract malignancies: breaking the deadlock.
about
Paclitaxel with cisplatin as salvage treatment for patients with previously treated advanced transitional cell carcinoma of the urothelial tract.Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter.Long-range effect of clinical trial interventions on quality of life.VDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis.
P2860
Chemotherapy for urothelial tract malignancies: breaking the deadlock.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Chemotherapy for urothelial tract malignancies: breaking the deadlock.
@ast
Chemotherapy for urothelial tract malignancies: breaking the deadlock.
@en
type
label
Chemotherapy for urothelial tract malignancies: breaking the deadlock.
@ast
Chemotherapy for urothelial tract malignancies: breaking the deadlock.
@en
prefLabel
Chemotherapy for urothelial tract malignancies: breaking the deadlock.
@ast
Chemotherapy for urothelial tract malignancies: breaking the deadlock.
@en
P2860
P356
P1476
Chemotherapy for urothelial tract malignancies: breaking the deadlock.
@en
P2093
P2860
P304
P356
10.1002/SSU.2980080511
P577
1992-09-01T00:00:00Z